Chesterfield Missouri, March 13, 2015:

Seventh Wave Laboratories LLC, a privately held Contract Research Organization (CRO) and leading provider of consulting and laboratory services supporting drug discovery and development, announces professional achievements of their Chief Scientific Officer.

Dr. Kristen Nikula, DVM, Ph.D, DACVP, FIATP is the Chief Scientific Officer of Seventh Wave Laboratories. In January, 2015 she was admitted as a Fellow in the International Academy of Toxicologic Pathology in the same week as her one hundredth publication was accepted.

John Sagartz, President, CEO and founder of Seventh Wave Laboratories announced “We congratulate Dr. Nikula on her recent accomplishments. She has been recognized by her peers for two career milestones related to her sustained scholarly activity.  Her focus on continuous professional development is obvious in achieving these milestones. Our company and clients benefit from her sustained scientific accomplishments”.

Dr. Nikula’s 100 publications are peer-reviewed publications, invited papers published in scientific journals, and toxicology or pathology book chapters. Her admission as a Fellow in the International Academy of Toxicologic Pathology (IATP) came after rigorous review of her professional accomplishments.

“The IATP is an academy of professionals that are globally recognized by their peers for their distinguished accomplishments and consistent dedication to the enhancement of toxicologic pathology. Becoming a Fellow of IATP represents the highest level of global recognition for sustained excellence of scientific contribution to toxicologic pathology.  Fellows of IATP are judged to be scientists who have achieved expert status in the practice of toxicologic pathology through scientific leadership and innovation which benefits society and their profession.”

Admission into the International Academy of Toxicologic Pathology is very selective. Criteria for acceptance are comprehensive and demanding. Fellows in the International Academy of Toxicology Pathology have a career with demonstrated accomplishments in multiple areas, including education, certification, experience, career progress, editorial responsibilities, professional society membership, publication, and podium presentations.

“We are fortunate to have a scientific leader of Dr. Nikula’s caliber as part of our executive leadership team. Her contributions to our strategic vision have positioned us to be a superior provider in our space, and her scientific contributions are sought after by our clients. These professional milestones underscore her reputation in our industry, and our commitment to our industry” commented Joe Flynn, Chief Commercial Officer of Seventh Wave Laboratories.

About Seventh Wave Laboratories 

Seventh Wave is a consulting-based contract research laboratory located in Chesterfield, MO that provides integrated services for discovery and preclinical drug development.  By integrating PK/ADME, Bioanalysis, Toxicology, and Pathology, our organization affords our clients a multi-disciplinary environment that accelerates their program with focused strategy and execution.